Manufacturers

Oscare Medical Oy

Äyritie 22 , 01510 Vantaa
Finland

Telephone +358 40 7324904
info@oscaremedical.fi

This company is co-exhibitor of
Wulff Entre Oy

Trade fair hall

  • Hall 15 / B05
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 15): stand B05

Fairground map

MEDICA 2016 fairground map: Hall 15

Contact

Mervi Turunen

Äyritie 22
01510 vantaa, Finland

Phone
+358407324904

Email
mervi.turunen@oscaremedical.fi

Mervi Turunen

Äyritie 22
01510 vantaa, Finland

Phone
+358407324904

Email
mervi.turunen@oscaremedical.fi

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.02  Imaging proceedings
  • 01.02.06  Ultrasound diagnostic equipment

Ultrasound diagnostic equipment

  • 01  Electromedical equipment / Medical Technology
  • 01.02  Imaging proceedings
  • 01.02.06  Ultrasound diagnostic equipment
  • 01.02.06.06  Ultrasonic devices for diagnosis of osteoporose and therapy follow-up

Ultrasonic devices for diagnosis of osteoporose and therapy follow-up

Our products

Product category: Ultrasound diagnostic equipment, Ultrasonic devices for diagnosis of osteoporose and therapy follow-up

OsCare Sono®

Convenient and reliable osteoporosis risk assessment
 
Convenient measurement
Measurement is performed conveniently on the table top using harmless ultrasound. Apart from rolling up a sleeve, no undressing is needed. The result is obtained in a few minutes and is shown in an easy-to-interpret report.
 
Cost efficient and flexible
No dedicated room or specialized staff are needed. Besides ultrasound gel, there are no consumables. The measurement is quick and the small device may be easily moved between locations. OsCare Sono® is well suitable also for low threshold locations, such as high street pharmacies.
 
Reliable risk assessment
OsCare Sono® measurement has been shown to correlate with bone cortical thickness, elasticity and mineral density, all important determinants of bone strength. OsCare Sono® sensitively recognizes patients diagnosed osteoporotic based on DXA (dual energy X-ray).

More Less

Company news

Date

Topic

Download

Nov 11, 2016

Oscare Medical showcases unique handheld ultrasound device for osteoporosis assessment at Medica 2016

Makes screening for osteoporosis simple, reliable and affordable

- Vantaa, Finland - Oscare Medical Oy announces that it will be demonstrating its handheld low frequency ultrasound device, the OsCare Sono® for osteoporosis assessment, at this year’s Medica at the Team Finland booth B5 in Hall 15. Medica, the world’s largest medical exhibition, will be held on 14th - 17th November in Düsseldorf, Germany.

Osteoporosis is estimated to affect 22 million women and 5.5 million men in Europe, with most of them unaware that they suffer from this silent disease until they suffer one or several low energy fractures. One out of three women and one out of five men 50 years old will experience osteoporotic fractures in their remaining lifetime.

The dual energy X-ray method (DXA) is the gold-standard for confirming a diagnosis of osteoporosis, but the expense, and limited availability, of DXA make it an impractical technique for screening people at an increased risk for osteoporosis. By assessing bone strength from the forearm radial bone using ultrasound, the OsCare Sono® allows for safe and inexpensive assessment of an individual’s osteoporosis risk. Because OsCare Sono® is easy to use and provides the measurement result in a matter of minutes, it is especially suitable for screening. Those individuals found to be at an increased risk for osteoporosis based on the OsCare Sono® measurement result, can be directed for further investigation with DXA, according to doctor’s judgement.

OsCare Sono® measurements have been shown to correlate with bone cortical thickness, bone elasticity and bone mineral density (BMD), including BMD of the deeper cortical layers – suggesting that the device uniquely offers enhanced sensitivity to early osteoporotic changes.

About Oscare Sono®

The Oscare Sono® is a compact, handheld device designed for osteoporosis risk assessment in clinics and low-threshold locations, such as high street pharmacies. The device attaches via a USB connector to a standard PC. A measurement is taken from the forearm over a few minutes using harmless ultrasound. An individual’s measurement is compared to the normal value observed in healthy young women, and the final Oscare Sono® result is ready for counseling.

About Oscare Medical

Oscare Medical was founded in 2007 to commercialize the results of a decade of research into bone health at the University of Jyväskylä, Finland. Since 2013, Oscare Medical has been majority-owned by Nasdaq-OMX-listed Revenio Group Corp which also markets the hugely successful Icare® tonometer product family. The Oscare Sono® is CE-marked and is on sale in several European and Middle Eastern countries. Oscare Medical is rapidly expanding its distribution partner network.
See: www.oscaremedical.com

Contact:

Mervi Turunen
Sales & Marketing Manager
T: +358 40 732 4904
mervi.turunen@oscaremedical.fi

More Less

About us

Company details

Oscare Medical develops, manufactures and markets a unique device, OsCare Sono®, for the early detection of osteoporosis. OsCare Sono® is based on measuring the speed of ultrasound in the forearm radius bone and it provides an easy, safe and cost effective means to screen for osteoporosis and osteopenia. The low ultrasound frequency used provides a good correlation with cortical thickness, bone mineral density and elasticity of the bone. The bidirectional measurement and operational logic help to eliminate the effect of soft tissue, resulting in a reliable measurement.

Osteoporosis screening with OsCare Sono® can conveniently take place for example in health centers, private clinics, gynecologist or orthopedist offices or pharmacies. Osteoporosis is a silent progressive disease that goes often unnoticed before a bone fracture, affecting almost 30 million people in the EU countries alone.

The OsCare Sono® device was granted a CE mark in late 2013. Oscare Medical is headquartered in Finland and is present in several European markets. Oscare Medical is currently looking for new distributors to expand its sales network in Europe. Please agree on an appointment if you are interested in co-operation.

More Less

Company data

Export content

> 75%

Foundation

2007

Area of business
  • Electromedical equipment / Medical Technology
  • Diagnostics